PCV114 FEASIBILITY OF USING REAL WORLD EVIDENCE TO INFORM DECISIONS ON CONDUCTING A COST EFFECTIVENESS ANALYSIS: AN EXAMPLE OF STROKE RISK REDUCTION THERAPIES IN ATRIAL FIBRILLATION
Abstract
Authors
O. Saunders R.L. Akehurst Y. Zhong S.L. Amorosi M. Gavaghan M. Hemstock T. Wong S. Panikker